Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
258.9000 2.10 (0.82%)
NSE Jun 05, 2025 11:50 AM
Volume: 306.3K
 

258.90
0.82%
Karvy
The company reported revenue growth of 8.9% for Q4FY15 over Q4FY14 and annual revenue reported a growth of 26.4% for FY15 over FY14.The company's Europe & UK segment reported growth of 25.7% while the US & North America reported growth of 65.3%. The improved product mix is reflected in operating margins which to 23.2% from 19.2% in FY14
Marksans Pharma Ltd. has gained 82.97% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended